Acadian Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $860K | Sell |
|
|||||
|
2024
Q3 | $2.66M | Sell |
|
|||||
|
2024
Q2 | $9.88M | Buy |
|
|||||
|
2024
Q1 | $7.44M | Sell |
|
|||||
|
2023
Q4 | $7.53M | Sell |
|
|||||
|
2023
Q3 | $8.43M | Buy |
|
|||||
|
2023
Q2 | $8.37M | Sell |
|
|||||
|
2023
Q1 | $11.7M | Sell |
|
|||||
|
2022
Q4 | $45.4M | Buy |
|
|||||
|
2022
Q3 | $35.3M | Buy |
|
|||||
|
2022
Q2 | $5.23M | Sell |
|
|||||
|
2022
Q1 | $6.38M | Buy |
|
|||||
|
2021
Q4 | $1.99M | Sell |
|
|||||
|
2021
Q3 | $61.3M | Buy |
|
|||||
|
2021
Q2 | $50.3M | Buy |
|
|||||
|
2021
Q1 | $10.8M | Buy |
|
|||||
|
2020
Q4 | $10.8M | Buy |
|
|||||
|
2020
Q3 | $5.85M | Buy |
|
|||||
|
2020
Q2 | $5.08M | Buy |
|
|||||
|
2020
Q1 | $1.18M | Buy |
|
|||||
|
2019
Q4 | $260K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $157K | Sell |
|
|||||
|
2018
Q4 | $3.12M | Sell |
|
|||||
|
2018
Q3 | $4.54M | Buy |
|
|||||
|
2018
Q2 | $784K | Sell |
|
|||||
|
2018
Q1 | $777K | Sell |
|
|||||
|
2017
Q4 | $2.96M | Sell |
|
|||||
|
2017
Q3 | $30.1M | Sell |
|
|||||
|
2017
Q2 | $28.5M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $179K | Buy |
|